OVARIAN CANCERS
Clinical trials for OVARIAN CANCERS explained in plain language.
Never miss a new study
Get alerted when new OVARIAN CANCERS trials appear
Sign up with your email to follow new studies for OVARIAN CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to make ovarian tumors operable
Disease control Not yet recruitingThis study tests whether a combination of two immunotherapy drugs (QL1706), a targeted therapy (bevacizumab), and standard chemotherapy can shrink advanced ovarian cancer before surgery. About 36 women with stage III-IV ovarian cancer will receive the treatment every 3 weeks, the…
Matched conditions: OVARIAN CANCERS
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New drug cocktail aims to shrink ovarian tumors before surgery
Disease control Not yet recruitingThis Phase 2 trial will test a combination of the experimental drug QL1706 with standard chemotherapy or with olaparib and intraperitoneal chemotherapy as a pre-surgery treatment for 50 women with advanced ovarian cancer. The goal is to see if this approach can shrink tumors enou…
Matched conditions: OVARIAN CANCERS
Phase: PHASE2 • Sponsor: Jiangsu Cancer Institute & Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC